Percutaneous vascular intervention after surgical shunting for portal hypertension.
Twenty percutaneous transluminal angioplasty (PTA) procedures and 13 percutaneous venous embolization (PVE) procedures were performed in 23 patients who either had or were at risk for the development of recurrent bleeding, hepatic encephalopathy, or both after surgical shunt placement for portal hypertension. PTA, performed in 12 patients with significant shunt stenoses, resulted in reduction or elimination of gradients in all patients; rebleeding has occurred in only one patient. Complications consisted of one fatal rupture of a mesocaval interposition vein graft and one balloon rupture requiring surgical removal. PVE, performed in 11 patients, resulted in measurable improvement in four of seven encephalopathic patients and temporary control in the two patients with intractable bleeding. Three patients underwent PVE prophylactically. PTA of graft strictures is a valuable treatment modality. Embolization may be helpful in selected cases of hepatic encephalopathy.
D000328:Adult; D000368:Aged; D000800:Angioplasty, Balloon; D004621:Embolization, Therapeutic; D005260:Female; D006501:Hepatic Encephalopathy / Q000628:therapy; D006801:Humans; D006975:Hypertension, Portal / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011170:Portasystemic Shunt, Surgical; D011182:Postoperative Care; D011183:Postoperative Complications / Q000628:therapy*; D012306:Risk